Marion Peters

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi request reprint Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
    Marion G Peters
    University of California, San Francisco, San Francisco, CA, USA
    Hepatology 44:1110-6. 2006
  2. doi request reprint Special populations with hepatitis B virus infection
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Hepatology 49:S146-55. 2009
  3. ncbi request reprint Managing hepatitis B coinfection in HIV-infected patients
    Marion G Peters
    Division of Gastroenterology, Box 0538, University of California, 513 Parnassus Ave, Room S 357, San Francisco, CA 94143 0538, USA
    Curr HIV/AIDS Rep 2:122-6. 2005
  4. ncbi request reprint Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States
    Marion G Peters
    University of California at San Francisco, San Francisco, CA 94143 0538, USA
    Hepatology 46:769-75. 2007
  5. ncbi request reprint Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
    Annie Luetkemeyer
    HIV AIDS Division, San Francisco General Hospital, University of California at San Francisco, CA 94110, USA
    J Acquir Immune Defic Syndr 41:31-6. 2006
  6. doi request reprint Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
  7. ncbi request reprint Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects
    Caroline M Behler
    Department of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143 1270, USA
    Clin Infect Dis 44:1375-83. 2007
  8. ncbi request reprint Animal models of autoimmune liver disease
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, California 94143 0538, USA
    Immunol Cell Biol 80:113-6. 2002
  9. pmc Influence of cannabis use on severity of hepatitis C disease
    Julie H Ishida
    Department of Medicine, University of California at San Francisco, San Francisco, California, USA
    Clin Gastroenterol Hepatol 6:69-75. 2008
  10. ncbi request reprint Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Gastroenterology 126:91-101. 2004

Research Grants

Detail Information

Publications32

  1. ncbi request reprint Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127
    Marion G Peters
    University of California, San Francisco, San Francisco, CA, USA
    Hepatology 44:1110-6. 2006
    ..In conclusion, over 48 weeks, treatment with either ADV or TDF resulted in clinically important suppression of serum HBV DNA. Both drugs are safe and efficacious for patients coinfected with HBV and HIV...
  2. doi request reprint Special populations with hepatitis B virus infection
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, CA 94143 0538, USA
    Hepatology 49:S146-55. 2009
    ..Further studies are particularly needed in assessing the safety and efficacy of therapy in pregnant women, in children, and in patients with hepatitis D and C virus coinfection...
  3. ncbi request reprint Managing hepatitis B coinfection in HIV-infected patients
    Marion G Peters
    Division of Gastroenterology, Box 0538, University of California, 513 Parnassus Ave, Room S 357, San Francisco, CA 94143 0538, USA
    Curr HIV/AIDS Rep 2:122-6. 2005
    ..Long-term management of hepatitis B includes monitoring for hepatocellular carcinoma. Two recent consensus conferences have provided excellent reviews of management of coinfection ...
  4. ncbi request reprint Differences between Caucasian, African American, and Hispanic patients with primary biliary cirrhosis in the United States
    Marion G Peters
    University of California at San Francisco, San Francisco, CA 94143 0538, USA
    Hepatology 46:769-75. 2007
    ..However, the mean age, male-to-female ratio, and seroprevalence of AMA positivity were similar between the 2 groups...
  5. ncbi request reprint Clinical presentation and course of acute hepatitis C infection in HIV-infected patients
    Annie Luetkemeyer
    HIV AIDS Division, San Francisco General Hospital, University of California at San Francisco, CA 94110, USA
    J Acquir Immune Defic Syndr 41:31-6. 2006
    ..Unexplained transaminase elevations in HIV-infected patients, including men who have sex with men, should trigger an evaluation for acute HCV infection...
  6. doi request reprint Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis
    Francis Y Yao
    Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
    Hepatology 48:819-27. 2008
    ..2% and 92.1%, respectively. No patient had HCC recurrence after a median posttransplantation follow-up of 25 months. The only factor predicting treatment failure was pretreatment alpha-fetoprotein >1,000 ng/mL...
  7. ncbi request reprint Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects
    Caroline M Behler
    Department of Hematology and Oncology, University of California San Francisco, San Francisco, CA 94143 1270, USA
    Clin Infect Dis 44:1375-83. 2007
    ....
  8. ncbi request reprint Animal models of autoimmune liver disease
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, California 94143 0538, USA
    Immunol Cell Biol 80:113-6. 2002
    ..The plethora of antigens implicated in autoimmune hepatitis in humans predicts that multiple mechanisms may play a role in precipitating disease in the susceptible individual...
  9. pmc Influence of cannabis use on severity of hepatitis C disease
    Julie H Ishida
    Department of Medicine, University of California at San Francisco, San Francisco, California, USA
    Clin Gastroenterol Hepatol 6:69-75. 2008
    ..Complications of HCV infection are primarily related to the development of advanced fibrosis and whether cannabis use is a risk factor for more severe fibrosis is controversial...
  10. ncbi request reprint Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B
    Marion G Peters
    Division of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Gastroenterology 126:91-101. 2004
    ....
  11. ncbi request reprint Alcohol use and hepatitis C
    Marion G Peters
    Department of Gastroenterology, University of California, San Francisco, CA 94143, USA
    Hepatology 36:S220-5. 2002
    ..The literature is inadequate to provide definitive recommendations regarding the effect of light to moderate alcohol use in patients with hepatitis C...
  12. ncbi request reprint Antiviral therapy: nucleotide and nucleoside analogs
    David J Quan
    Department of Clinical Pharmacy, University of California, San Francisco, 521 Parnassus Avenue, Room C 152, Box 0622, San Francisco, CA 94143 0622, USA
    Clin Liver Dis 8:371-85. 2004
    ..Other nucleoside analogs are in various stages of development, including MCC-478 and DAPD. In the future, clinicians will have a plethora of reagents to chose from, and combination therapies may be invoked...
  13. pmc Age-dependent hepatic lymphoid organization directs successful immunity to hepatitis B
    Jean Publicover
    Department of Medicine, UCSF, San Francisco, California, USA
    J Clin Invest 123:3728-39. 2013
    ..Taken together, these results identify some of the immunological mechanisms necessary for effective control of HBV. ..
  14. pmc Adipose tissue and metabolic factors associated with steatosis in HIV/HCV coinfection: histology versus magnetic resonance spectroscopy
    Alireza Ghotb
    Department of Medicine, California Pacific Medical Center, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 55:228-31. 2010
    ..We compared magnetic resonance spectroscopy (MRS) measurement of steatosis to histology in HIV/HCV-coinfected patients and explored the associated adipose tissue and metabolic factors...
  15. ncbi request reprint Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women
    Judith I Tsui
    Department of Medicine, University of California San Francisco, San Francisco, CA, USA
    Clin Infect Dis 45:736-40. 2007
    ..CD4 cell counts of <200 cells/mm3 were more common among occult HBV-infected women than among those without occult HBV infection. Aminotransferase levels did not appear to be associated with being positive for HBV DNA...
  16. pmc Hepatitis resulting from liver-specific expression and recognition of self-antigen
    James Buxbaum
    Division of Gastroenterology, University of California, San Francisco, CA 94143, USA
    J Autoimmun 31:208-15. 2008
    ..This model of T cell recognition of antigen on hepatocytes may be used to understand many liver-specific aspects of the immune response in autoimmune hepatitis...
  17. pmc Untreated HIV infection is associated with higher blood alcohol levels
    Elinore F McCance-Katz
    Department of Psychiatry, Addiction Medicine Research, University of California San Francisco, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 60:282-8. 2012
    ..This pilot study examines the relationship of untreated HIV infection to blood alcohol concentrations (BAC) relative to BAC after initiation of antiretroviral therapy (ART)...
  18. ncbi request reprint Diagnosis and management of hepatitis B virus and HIV coinfection
    Marion G Peters
    Hepatology Research, University of California San Francisco, San Francisco, CA, USA
    Top HIV Med 15:163-6. 2007
    ..This article summarizes a presentation on HIV and HBV coinfection made by Marion G. Peters, MD, at an International AIDS Society-USA Continuing Medical Education course in San Francisco in May 2007...
  19. ncbi request reprint End-stage liver disease in HIV disease
    Marion G Peters
    University of California San Francisco, San Francisco, CA, USA
    Top HIV Med 17:124-8. 2009
    ..Peters, MD, at the International AIDS Society-USA continuing medical education program held in Chicago in May 2009. The original presentation is available as a Webcast at www.iasusa.org...
  20. ncbi request reprint Role of alphavbeta6 integrin in acute biliary fibrosis
    Bruce Wang
    Liver Center, Department of Medicine, University of California, San Francisco, USA
    Hepatology 46:1404-12. 2007
    ..In a survey of human liver disease, expression of alphavbeta6 is increased in acute, but not chronic, biliary injury and is localized to cholangiocyte-like cells...
  21. ncbi request reprint De novo malignancies following liver transplantation: a case-control study with long-term follow-up
    Francis Y Yao
    Department of Medicine, University of California San Francisco, San Francisco, CA 94143 0538, USA
    Clin Transplant 20:617-23. 2006
    ..Long-term survival data on de novo malignancy are limited following orthotopic liver transplantation (OLT) when compared with controls without malignancies...
  22. ncbi request reprint Novel model of antigen-specific induction of bile duct injury
    James Buxbaum
    Department of Medicine, University of California, San Francisco, California 94143 0538, USA
    Gastroenterology 131:1899-906. 2006
    ..Biliary-directed inflammation is an important cause of acute and chronic liver disease. We developed and characterized a transgenic mouse model of immune-mediated hepatobiliary injury...
  23. ncbi request reprint Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients
    Kenneth E Sherman
    Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Gastroenterology 128:313-27. 2005
    ..HCV-monoinfected patients. Reasons for this remain unclear. This study evaluated kinetic parameters and treatment responses in co-infected vs monoinfected patients...
  24. ncbi request reprint Methotrexate (MTX) plus ursodeoxycholic acid (UDCA) in the treatment of primary biliary cirrhosis
    Burton Combes
    The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 9151, USA
    Hepatology 42:1184-93. 2005
    ..In conclusion, methotrexate when added to UDCA for a median period of 7.6 years had no effect on the course of PBC treated with UDCA alone...
  25. ncbi request reprint Viral hepatitis in HIV infection
    Margaret James Koziel
    Division of Infectious Disease, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA 02215, USA
    N Engl J Med 356:1445-54. 2007
  26. ncbi request reprint Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    Raymond T Chung
    Massachusetts General Hospital, Boston, MA 02114, USA
    N Engl J Med 351:451-9. 2004
    ..We conducted a multicenter, randomized trial comparing peginterferon plus ribavirin with interferon plus ribavirin for the treatment of chronic hepatitis C in persons coinfected with HIV...
  27. doi request reprint The challenge of diagnosing autoimmune hepatitis: less is more
    Gina Choi
    Hepatology 48:10-2. 2008
  28. ncbi request reprint Recurrent primary biliary cirrhosis: peritransplant factors and ursodeoxycholic acid treatment post-liver transplant
    Jennifer E Guy
    Department of Medicine, University of California San Francisco, CA 94143 0538, USA
    Liver Transpl 11:1252-7. 2005
    ..In conclusion, recurrent PBC is not infrequent post-OLT, and ursodeoxycholic acid can be used with some benefit post-OLT. Treatment effects on long-term survival are not known...
  29. ncbi request reprint Hepatitis C and alcohol: fundamental and translational research directions
    Timothy R Morgan
    Department of Medicine, Veterans Adminstration Medical Center, Long Beach, California, USA
    Alcohol Clin Exp Res 27:726-31. 2003
    ..This article summarizes the panel's deliberations and their recommendations for future research on alcohol and hepatitis C...
  30. ncbi request reprint Effects of HCV treatment on cytokine expression during HCV/HIV coinfection
    Jason T Blackard
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    J Interferon Cytokine Res 26:834-8. 2006
    ....
  31. ncbi request reprint Viral factors associated with cytokine expression during HCV/HIV co-infection
    Jason T Blackard
    Gastrointestinal Unit, Massachusetts General Hospital, Boston, MA 02114, USA
    J Interferon Cytokine Res 27:263-9. 2007
    ..Further studies are warranted to identify noninvasive markers of liver disease for the clinical management of HCV disease, particularly when liver biopsies have not been performed or are contraindicated...
  32. ncbi request reprint Prolonged follow-up of patients in the U.S. multicenter trial of ursodeoxycholic acid for primary biliary cirrhosis
    Burton Combes
    University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 9151, USA
    Am J Gastroenterol 99:264-8. 2004
    ....

Research Grants5

  1. HCV & ALCHOOL-- EPIDEMIOLOGY & HOST-VIRUS CORRELATES
    Marion Peters; Fiscal Year: 2004
    ....